Viewing 0 reply threads
  • Author
    • #20884

        I got a letter from my insurance denying coverage of plasmApheresis as there is “no evidence showing long-term benefit in MG”

        I am LRP-4 positive and there are currently NO therapies that are currently approved for non-MUSK/ non-ACHR (+) MG; primarily b/c no studies are being done is this population—-something that is a chronic problem having a rare subtype of a rare disease—there is no financial incentive to target this subset.

        My disease course is riddled with hospitalizations for respiratory failure; I’ve been on high dose steroids (gave me suicidal ideation, AVN in my R hip and not many options for IV access; IVIG (which worked for a few years, but the the hospitalizations started again, during which I responded well to PLEX (plasmApheresis). I was initially getting it monthly as an OP, then q3wk and then q2wk—at which point my hospitalizations drastically decreased—-that was >5yrs ago.

        I have 6mo to appeal and don’t know what the best strategy is, nor does my neurologist—I would appreciate any advice


    Viewing 0 reply threads
    • You must be logged in to reply to this topic.

    ©2023 KLEO Template a premium and multipurpose theme from Seventh Queen


    We're not around right now. But you can send us an email and we'll get back to you, asap.


    Log in with your credentials


    Forgot your details?

    Create Account